Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.27B |
| 2 |
Zimmer Biomet
ZBH
|
+$3.42B |
| 3 |
TransUnion
TRU
|
+$1.8B |
| 4 |
Qualcomm
QCOM
|
+$587M |
| 5 |
Alibaba
BABA
|
+$434M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.06B |
| 2 |
Pfizer
PFE
|
+$895M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$631M |
| 4 |
RTX Corp
RTX
|
+$546M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$516M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.41% |
| 2 | Healthcare | 8.04% |
| 3 | Technology | 7.66% |
| 4 | Energy | 6.94% |
| 5 | Consumer Discretionary | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CEW
3226
WisdomTree Emerging Currency Strategy Fund
CEW
$15.8M
| $3.6M | ﹤0.01% |
197,897
-43,119
| -18% | -$798K |
|
|
ADVM
3227
DELISTED
Adverum Biotechnologies
ADVM
| $3.59M | ﹤0.01% |
+22,130
| New | +$7.47M |
|
3228
PUT
KLA
KLAC
$239B
| $3.59M | ﹤0.01% |
639,000
-640,000
| -50% | -$3.74M |
|
3229
CALL
Travelers Companies
TRV
$78.1B
| $3.59M | ﹤0.01% |
37,100
+5,500
| +17% | +$563K |
|
3230
CALL
Vertex Pharmaceuticals
VRTX
$121B
| $3.58M | ﹤0.01% |
29,000
-4,400
| -13% | -$554K |
|
3231
Halozyme
HALO
$9.79B
| $3.57M | ﹤0.01% |
158,151
-73,324
| -32% | -$1.29M |
|
|
RDC
3232
DELISTED
Rowan Companies Plc
RDC
| $3.56M | ﹤0.01% |
168,837
-16,728
| -9% | -$354K |
|
|
GRP.U
3233
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $3.56M | ﹤0.01% |
104,192
+4,473
| +4% | +$154K |
|
|
NSR
3234
DELISTED
Neustar Inc
NSR
| $3.56M | ﹤0.01% |
121,747
-104,213
| -46% | -$2.95M |
|
3235
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.5B
| $3.56M | ﹤0.01% |
80,500
+32,700
| +68% | +$1.39M |
|
3236
PUT
Tenaris
TS
$28.9B
| $3.55M | ﹤0.01% |
131,400
+125,500
| +2,127% | +$3.74M |
|
|
YOKU
3237
CALL
DELISTED
YOUKU TUDOU INC.(CAYMAN ISLS)
YOKU
| $3.54M | ﹤0.01% |
144,400
-122,200
| -46% | -$2.76M |
|
|
VSI
3238
DELISTED
Vitamin Shoppe Inc.
VSI
| $3.54M | ﹤0.01% |
94,984
+4,576
| +5% | +$183K |
|
3239
Calumet Specialty Products
CLMT
$3.85B
| $3.54M | ﹤0.01% |
139,012
-56,292
| -29% | -$1.49M |
|
3240
PUT
TotalEnergies
TTE
$195B
| $3.53M | ﹤0.01% |
71,800
+1,000
| +1% | +$51.8K |
|
|
TECD
3241
DELISTED
Tech Data Corp
TECD
| $3.53M | ﹤0.01% |
61,303
-7,329
| -11% | -$441K |
|
3242
Icahn Enterprises
IEP
$5.24B
| $3.52M | ﹤0.01% |
40,621
-19,979
| -33% | -$1.8M |
|
|
CLR
3243
CALL
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $3.52M | ﹤0.01% |
83,100
-26,200
| -24% | -$1.25M |
|
3244
Werner Enterprises
WERN
$2.24B
| $3.51M | ﹤0.01% |
133,622
-70,607
| -35% | -$2.01M |
|
3245
PUT
Puma Biotechnology
PBYI
$404M
| $3.5M | ﹤0.01% |
30,000
-9,700
| -24% | -$1.76M |
|
3246
CALL
PVH
PVH
$4B
| $3.5M | ﹤0.01% |
30,400
-63,800
| -68% | -$6.93M |
|
3247
WisdomTree Global High Dividend Fund
DEW
$148M
| $3.5M | ﹤0.01% |
+80,615
| New | +$3.7M |
|
3248
CALL
Abercrombie & Fitch
ANF
$4.42B
| $3.5M | ﹤0.01% |
162,500
-10,600
| -6% | -$233K |
|
|
MRLN
3249
DELISTED
Marlin Business Services Corp
MRLN
| $3.49M | ﹤0.01% |
206,665
| – | – |
|
3250
PUT
Darden Restaurants
DRI
$23.3B
| $3.48M | ﹤0.01% |
54,816
+41,392
| +308% | +$2.45M |
|
Similar funds
Goldman Sachs's Q2 2015 Portfolio in Review
As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.
By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.
- Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
- Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
- Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
- Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
- Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
- Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.
Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.